Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Kognitos CEO Binny Gill to Deliver Audit-Grade AI Playbook for Finance at Ai4 2026
-
CapEx Finance Index June 2026: Demand Rebounds and Continues Upward Trend
-
Legend Biotech to Host Investor Conference Call on Second Quarter 2026 Results
-
Arcana Collective Launches Colorado Nursery Sciences, Bringing Biosecurity, Diverse Genetics and Cost Savings To Colorado Cultivators
-
Exyn Technologies Wins New Mining, Infrastructure, and Government Contracts Across Three Continents
-
authID and MajorKey Technologies Expand Partnership Through OEM Agreement, Embedding Verified and PrivacyKey Across MajorKey's Identity Security Portfolio
-
Slate Medicines Establishes Clinical and Scientific Advisory Boards to Advance Next-Generation Migraine Prevention Therapeutics
-
Kratos Completes Construction of $50 Million State-of-the-Art Hypersonic Systems Payload Integration Facility in Indiana Ahead of Schedule
-
Zingtree Names New CTO as Company Accelerates Product Roadmap for Trusted Agentic Customer Experiences in Complex Products and Regulated Industries
-
CorVascular Named Exclusive U.S. Importer and Vascular Distributor for ASUS FDA-Cleared Ultrasound Portfolio
-
Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce
-
AssetMark Study Finds Investment Management Outsourcing Is Increasingly Linked to Stronger Advisor Growth Outcomes
-
Intrado’s Emergency Routing Service Now Integrated with Webex Calling Multi-Tenant to Advance E911 Compliance
-
AlphaSense Announces AlphaSummit 2026 to Explore the Future of Decision-Grade AI
-
Registration Opens for Dayforce Discover 2026: Rediscover the Work You’re Meant to Do
-
Omnea triples revenue in twelve months as enterprises choose agentic operating system for procurement
-
Abundia Global Impact Group Announces Completion of the Process Design Package with Alterra Energy
-
Magna Secures 800V eDrive Program Award With Chery
-
Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the First Fiscal Quarter, and Declaration of Common Stock Distributions for the Months Ending October, November,
-
DealMachine Expands Into an AI-Native Property Intelligence Platform
-
Lucky Hand Acquires Vane Capital to Expand Its Creative Economy Platform
-
ZuriQ raises $25.5 million to scale new groundbreaking 2D quantum architecture
-
Who benefits from negotiating? Social class makes a difference
-
Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides
-
Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
-
Implicity’s Next-Generation ILR ECG Analyzer Earns FDA Clearance
-
Correction: KN Energies and Indel Petro Sign Memorandum of Understanding in Vietnam
-
Trevi Therapeutics to Participate in Upcoming August Conferences
-
Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference
-
Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
-
Canso Credit Income Fund Completes Conversion to Exchange-Traded Fund and Commences Trading on Toronto Stock Exchange
-
PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc.
-
Palvella Therapeutics to Host Second Quarter 2026 Financial Results and Corporate Update Conference Call on August 4, 2026
-
NIOB completes 2026 drill program at Bardy
-
Riot Announces Second Quarter 2026 Earnings Conference Call
-
ZenaTech’s ZenaDrone Begins Testing Phase for Interceptor P-1 Counter-UAS Drone Platform
-
Kazia Therapeutics Announces the Filing of Provisional Patent for Novel Strategy, Supported by Preclinical Data, to Prevent Metastatic Recurrence in Triple-Negative Breast Cancer
-
3D Systems Enables First FDA Clearance for Implant from a Point-of-Care Institution
-
Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD)
-
Hubbell Reports Second Quarter 2026 Results
-
PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc.
-
Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET
-
Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution
-
Judge Consulting Group President and CTO John Battaglia Named to City & State PA’s 2026 “40 in Their 40s” List
-
Judge Consulting Group President and CTO John Battaglia Named to City & State PA’s 2026 “40 in Their 40s” List
-
DCX’s DexTrader Announces Upgrade, Targeting On-Chain Yield-Bearing Collateralized Derivatives Data Services Segment
-
-
Xali Gold Continues to Demonstrate the Scale and Grade of Gold Mineralization at Pico Machay
-
Altimmune Announces Positive Topline Results from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder
-
Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus
